← Open Payments lookup

CHRISTOPHER MILSTEAD: Open Payments

NPI 1932216090 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,509 in 60 payments from 15 companies in 2025. Trend: 2023 $1,709 · 2024 $1,900 · 2025 $1,509

Food & beverage: $1,502Education: $8
CompanyPaymentsAmount
Axsome Therapeutics, Inc.7$261
Otsuka America Pharmaceutical, Inc.10$226
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$185
ABBVIE INC.7$157
Supernus Pharmaceuticals, Inc.5$155
Neurocrine BioSciences, Inc.5$139
Teva Pharmaceuticals USA, Inc.3$74
Alkermes, Inc.4$67
Takeda Pharmaceuticals U.S.A., Inc.3$59
Janssen Pharmaceuticals, Inc2$54

Products named: Auvelity, CAPLYTA, REXULTI, VRAYLAR, Qelbree, INGREZZA, AUSTEDO XR, ARISTADA.

Industry payments across AR — which companies pay providers there.